Delivery Order SPE2DB25D7056-SPE2DB25FTMVL
- Not listed
- The Defense Logistics Agency awarded a $20,176.14 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 30, 2025, with performance at the contractor's Conshohocken, Pennsylvania facility. The contract contains no set-aside designation, reflecting AmerisourceBergen's qualification to compete in open federal procurement....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 per unit, with a ceiling value of $12,891.33. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for completion by October 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30s, with a ceiling value of $65,401.89 and a firm fixed price structure. This delivery order, which represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA, is scheduled for completion by November 10, 2025. The award was made through open competition with no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units, valued at $3,568.75. This is a firm fixed-price delivery order with no set-aside designation, reflecting open competitive procurement. The order is scheduled for completion by October 22, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract is valued at $63,889.39 and is classified as a firm fixed price delivery order with an ultimate completion date of September 2, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 tablets, with a ceiling value of $2,915.55. This is a firm fixed-price delivery order with an ultimate completion date of June 20, 2025, and represents a non-competitive set-aside award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $12,635.04 to AmerisourceBergen Drug Corp for the supply of Descovy 200-25 mg tablets (30-count units) on October 31, 2025, with completion scheduled for November 3, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the...
- The Defense Logistics Agency awarded a delivery order valued at $28,993.50 to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This is a firm fixed price contract with an ultimate completion date of September 10, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the contractor's demonstrated...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units, with a contract ceiling value of $13,765.22. This is a firm fixed price delivery order with no set-aside designation, representing a competitive award. The order is set for ultimate completion on November 6, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for pharmaceutical supply on July 23, 2025, with an ultimate completion date of July 24, 2025. The contract, valued at $3,835.11 under a firm fixed-price arrangement, covers the delivery of Descovy 200-25 mg tablets in quantities of 30 units. This delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DB25D7056Indefinite Delivery Contract
- SPE2DB25D7056-SPE2DB25FTMVLDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This competitive award, valued at $10,669.37 with firm fixed pricing, represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The delivery order will be fulfilled from the contractor's Conshohocken, Pennsylvania location, with an ultimate completion date of July 24, 2025. No set-aside designation was applied to this award. This delivery order falls under AmerisourceBergen Drug Corp's $999,999,999.00 Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which extends through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen maintains a substantial portfolio of federal medical supply contracts with DLA and supports the Defense Health Agency and other government healthcare systems. The Descovy tablets procured under this order support antiviral pharmaceutical needs within the military's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.7k | 7/23/25 |